Identification of metabolomics panels for potential lung cancer screening by analysis of exhaled breath condensate

Journal of Breath Research

Volumn 10, Issue 2, 2016, Pages

  Peralbo Molina, A ^a   Calderon Santiago M ^a   Priego Capote, F ^a   Jurado Gamez B ^a,b   Luque De Castro, M D ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

biomarker panel; exhaled breath condensate; GC TOF MS; lung cancer; metabolomics

Indexed keywords

ADULT; AGED; ARTICLE; BODY FLUID; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXHALED BREATH CONDENSATE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MATHEMATICAL COMPUTING; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; BREATH ANALYSIS; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; PROCEDURES;

BIOLOGICAL MARKER;

AGED; AREA UNDER CURVE; BIOMARKERS; BREATH TESTS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METABOLOMICS; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84978734580     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/10/2/026002     Document Type: Article

References (38)

1. Jemal A, Bray F, Center M M, Ferlay J, Ward E and Forman D 2011 Global cancer statistics CA Cancer J. Clin. 61 69-90
2. Burney P et al 2014 Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a bold analysis Thorax 69 465-73
3. Jemal A, Center M M, DeSantis C and Ward E M 2010 Global patterns of cancer incidence and mortality rates and trends Cancer Epidemiol. Biomark. Prev. 19 1893-907
4. Boiselle P M 2013 Computed tomography screening for lung cancer JAMA 309 1163-70
5. Álvarez-Sánchez B, Priego-Capote F and Luque de Castro M D 2010 Metabolomics analysis I. Selection of biological samples and practical aspects preceding sample preparation TrAC Trends Anal. Chem. 29 111-9
6. Calderón-Santiago M, Priego-Capote F, Jurado-Gámez B and Luque de Castro M D 2014 Optimization study for metabolomics analysis of human sweat by liquid chromatography-tandem mass spectrometry in high resolution mode J. Chromatogr. A 1333 70-8
7. Kim J O, Gazala S, Razzak R, Guo L, Ghosh S, Roa W H and Bedard E L R 2015 Non-small cell lung cancer detection using MicroRNA expression profiling of bronchoalveolar lavage fluid and sputum Anticancer Res. 35 1873-80
8. Phillips M, Gleeson K, Hughes J M, Greenberg J, Cataneo R N, Baker L and McVay W P 1999 Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study Lancet 353 1930-3
9. Phillips M, Cataneo R N, Cummin A R C, Gagliardi A J, Gleeson K, Greenberg J, Maxfield R A and Rom W N 2003 Detection of lung cancer with volatile markers in the breath Chest 123 2115-23
10. Phillips M et al 2007 Prediction of lung cancer using volatile biomarkers in breath Cancer Biomark. 3 95-109
11. Wang Y, Hu Y, Wang D, Yu K, Wang L, Zou Y, Zhao C, Zhang X, Wang P and Ying K 2012 The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines Cancer Biomark. 11 129-37
12. Kubáň P and Foret F 2013 Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review Anal. Chim. Acta 805 1-18
13. Costa C, Bucca C, Bergallo M, Solidoro P, Rolla G and Cavallo R 2011 Unsuitability of exhaled breath condensate for the detection of herpesviruses DNA in the respiratory tract J. Virol. Methods 173 384-6
14. Dragonieri S, Brinkman P, Mouw E, Zwinderman A H, Carratú P, Resta O, Sterk P J and Jonkers R E 2013 An electronic nose discriminates exhaled breath of patients with untreated pulmonary sarcoidosis from controls Respir. Med. 107 1073-8
15. Hunt J 2002 Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease J. Allergy Clin. Immunol. 110 28-34
16. Mazzatenta A, Di Giulio C and Pokorski M 2013 Pathologies currently identified by exhaled biomarkers Respir. Physiol. Neurobiol. 187 128-34
17. Peralbo-Molina A, Calderón-Santiago M, Priego-Capote F, Jurado-Gámez B and Luque de Castro M D 2015 Development of a method for metabolomic analysis of human exhaled breath condensate by gas chromatography-mass spectrometry in high resolution mode Anal. Chim. Acta 887 118-26
18. Calderón-Santiago M, Priego-Capote F, Turck N, Robin X, Jurado-Gámez B, Sanchez J C and Luque de Castro M D 2015 Human sweat metabolomics for lung cancer screening Anal. Bioanal. Chem. 407 5381-92
19. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C and Müller M 2013 PanelomiX: a threshold-based algorithm to create panels of biomarkers Transl. Proteom. 1 57-64
20. Kayode R M O and Afolayan A J 2015 Cytotoxicity and effect of extraction methods on the chemical composition of essential oils of Moringa oleifera seeds J. Zhejiang Univ. Sci. B 16 680-9
21. Pierce C H, Chen Y, Dills R L, Kalman D A and Morgan M S 2002 Toluene metabolites as biological indicators of exposure Toxicol. Lett. 129 65-76
22. Kim K-W, Won Y L and Ko K S 2015 Ethnic differences in the metabolism of toluene: comparisons between Korean and foreign workers exposed to toluene Toxicol. Res. 31 25-32
23. Inoue O, Seiji K, Watanabe T, Nakatsuka H, Jin C, Liu S-J and Ikeda M 1993 Effects of smoking and drinking on excretion of hippuric acid among toluene-exposed workers Int. Arch. Occup. Environ. Health 64 425-30
24. World Health Organization 2000 Air Quality Guidelines for Europe (WHO Regional Publications, European Series No. 91) (Copenhagen: WHO Regional Publications) pp 1-20
25. Nakajima T, Wang R-S, Elovaara E, Gonzalez F J, Gelboin H V, Raunio H, Pelkonen O, Vainio H and Aoyama T 1997 Toluene metabolism by cDNA-expressed human hepatic cytochrome P450 Biochem. Pharmacol. 53 271-7
26. Liang Y, Van Nostrand J D, Wang J, Zhang X, Zhou J and Li G 2009 Microarray-based functional gene analysis of soil microbial communities during ozonation and biodegradation of crude oil Chemosphere 75 193-9
27. Darrall K G, Figgins J A, Brown R D and Phillips G F 1998 Determination of benzene and associated volatile compounds in mainstream cigarette smoke Analyst 123 1095-101
28. Quehenberger O et al 2010 Lipidomics reveals a remarkable diversity of lipids in human plasma J. Lipid Res. 51 3299-305
29. Phillips M 1999 Variation in volatile organic compounds in the breath of normal humans J. Chromatogr. B 729 75-88
30. Phillips M et al 2008 Detection of lung cancer using weighted digital analysis of breath biomarkers Clin. Chim. Acta 393 76-84
31. Kabara J J, Swieczkowski D M, Conley A J and Truant J P 1972 Fatty acids and derivatives as antimicrobial agents Antimicrob. Agents Chemother. 2 23-8
32. Malapermal V, Botha I, Krishna S B N and Mbatha J N 2015 Enhancing antidiabetic and antimicrobial performance of Ocimum basilicum, and Ocimum sanctum (L.) using silver nanoparticles Saudi J. Biol. Sci. at press (doi: 10.1016/j.sjbs.2015.06.026)
33. Pragman A A, Kim H B, Reilly C S, Wendt C and Isaacson R E 2012 The lung microbiome in moderate and severe chronic obstructive pulmonary disease PLoS ONE 7 e47305
34. Sethi S and Murphy T F 2008 Infection in the pathogenesis and course of chronic obstructive pulmonary disease N. Engl. J. Med. 359 2355-65
35. Houghton A M 2013 Mechanistic links between COPD and lung cancer Nat. Rev. Cancer 13 233-45
36. Schwabe R F and Jobin C 2013 The microbiome and cancer Nat. Rev. Cancer 13 800-12
37. Dickson R P, Erb-Downward J R and Huffnagle G B 2013 The role of the bacterial microbiome in lung disease Expert Rev. Respir. Med. 7 245-57
38. Nair B 2001 Final report on the safety assessment of benzyl alcohol, benzoic acid, and sodium benzoate Int. J. Toxicol. 20 23-50